Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the Western world. It is more prevalent in male gender, and with increasing age, obesity, and insulin resistance. Besides weight loss, there are limited treatment options. The use of anti-diabetic medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Dokmak, Amr, Almeqdadi, Mohammad, Trivedi, Hirsh, Krishnan, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669193/
https://www.ncbi.nlm.nih.gov/pubmed/31388398
http://dx.doi.org/10.4254/wjh.v11.i7.562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669193/
https://www.ncbi.nlm.nih.gov/pubmed/31388398
http://dx.doi.org/10.4254/wjh.v11.i7.562

Ejemplares similares